Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Ependymoma · Medulloblastoma · Glioblastoma · Primary Brain Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Augusta University, Georgia Cancer Center, Augusta, Georgia, United States
Contact: Study coordinator (Theodore S Johnson, MD, PhD) · thjohnson@augusta.edu · 706-721-4962
Contact: Study coordinator (Robin Dobbins, RN) · rdobbins@augusta.edu · 706-721-2154
Contact: Principal Investigator (Theodore S Johnson, MD, PhD)

Study leads

Theodore S. Johnson, MD, PhD
Principal Investigator
Augusta University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Central Nervous System Neoplasms · Glioblastoma · Gliosarcoma, Adult

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Solid Tumor Cancer · Medulloblastoma · High Risk Neuroblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Boadilla del Monte, Spain

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Glioma · Medulloblastoma · Ependymoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Medulloblastoma Recurrent · Ependymoma Recurrent · ATRT Recurrent

Abroad (travel likely)RecruitingPHASE2

Chicago, United States · Boston, United States